{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:53:38Z","timestamp":1791910418435,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20323"],"award-info":[{"award-number":["U22A20323"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118260","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:34:50Z","timestamp":1784129690000},"page":"118260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["EFO2 promotes triple-negative breast cancer progression and reduces CD8+ T cell-mediated killing by acetylating USF1 to enhance SLC2A1-mediated glycolysis"],"prefix":"10.1016","volume":"253","author":[{"given":"Lin","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junning","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2026.118260_b0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1158\/1078-0432.CCR-16-3001","article-title":"Breast cancer immunotherapy: facts and hopes","volume":"24","author":"Emens","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118260_b0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ccell.2020.12.001","article-title":"Integrin \u03b1v\u03b26-TGF\u03b2-SOX4 pathway drives immune evasion in triple-negative breast cancer","volume":"39","author":"Bagati","year":"2021","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118260_b0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.bcp.2026.118260_b0020","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bcp.2026.118260_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108500","article-title":"Lactate limits T cell proliferation via the NAD(H) redox state","volume":"33","author":"Quinn","year":"2020","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.bcp.2026.118260_b0030","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to Tcell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.bcp.2026.118260_b0035","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1073\/pnas.1911936117","article-title":"Multivalent interaction of ESCO2 with the replication machinery is required for sister chromatid cohesion in vertebrates","volume":"117","author":"Bender","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"37","key":"10.1016\/j.bcp.2026.118260_b0040","doi-asserted-by":"crossref","first-page":"9906","DOI":"10.1073\/pnas.1708291114","article-title":"Esco1 and Esco2 regulate distinct cohesin functions during cell cycle progression","volume":"114","author":"Alomer","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.bcp.2026.118260_b0045","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1093\/nar\/gkad533","article-title":"ATM-ESCO2-SMC3 axis promotes 53BP1 recruitment in response to DNA damage and safeguards genome integrity by stabilizing cohesin complex","volume":"51","author":"Fu","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118260_b0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13046-021-01858-1","article-title":"ESCO2 promotes lung adenocarcinoma progression by regulating hnRNPA1 acetylation","volume":"40","author":"Zhu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118260_b0055","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.7150\/ijbs.69134","article-title":"USF1-ATRAP-PBX3 Axis Promote Breast Cancer Glycolysis and Malignant Phenotype by Activating AKT\/mTOR Signaling","volume":"18","author":"Wang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118260_b0060","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1096\/fj.201600961RR","article-title":"Histone deacetylase inhibitor apicidin increases expression of the \u03b1-secretase ADAM10 through transcription factor USF1-mediated mechanisms","volume":"31","author":"Hu","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2026.118260_b0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.gdata.2015.09.020","article-title":"Transcriptional profiling of differentially expressed long non-coding RNAs in breast cancer","volume":"6","author":"Wang","year":"2015","journal-title":"Genom. Data"},{"issue":"1","key":"10.1016\/j.bcp.2026.118260_b0070","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1186\/s12885-023-11527-5","article-title":"ESCO2 promotes hypopharyngeal carcinoma progression in a STAT1-dependent manner","volume":"23","author":"Hu","year":"2023","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.bcp.2026.118260_b0075","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.7150\/jca.112087","article-title":"ESCO2 promotes the proliferation of hepatocellular carcinoma through the PI3K\/AKT\/ mTOR signaling pathway","volume":"16","author":"Chen","year":"2025","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.118260_b0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-024-01975-3","article-title":"LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1\/PLK3\/HIF1\u03b1 signaling","volume":"23","author":"Luo","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.118260_b0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13058-022-01520-4","article-title":"SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance","volume":"24","author":"Liu","year":"2022","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.118260_b0090","first-page":"1284","article-title":"SETDB1 induces epithelial\u2011mesenchymal transition in breast carcinoma by directly binding with Snail promoter","volume":"41","author":"Yang","year":"2019","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2026.118260_b0095","first-page":"416","article-title":"YEATS4 is associated with poor prognosis and promotes epithelial-to-mesenchymal transition and metastasis by regulating ZEB1 expression in breast cancer","volume":"11","author":"Li","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"10","key":"10.1016\/j.bcp.2026.118260_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116400","article-title":"YEATS4 reads histone crotonylation to promote fatty acid metabolism and cancer cell stemness","volume":"44","author":"Peng","year":"2025","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bcp.2026.118260_b0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41588-019-0541-5","article-title":"ARID1A influences HDAC1\/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response","volume":"52","author":"Nagarajan","year":"2020","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bcp.2026.118260_b0110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41588-019-0554-0","article-title":"ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer","volume":"52","author":"Xu","year":"2020","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2026.118260_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113194","article-title":"SEZ6L2, regulated by USF1, accelerates the growth and metastasis of breast cancer","volume":"417","author":"Chen","year":"2022","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118260_b0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2019.0210","article-title":"Metabolic reprogramming in triple-negative breast cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118260_b0125","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1038\/s41467-020-18020-8","article-title":"GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118260_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-024-06014-9","article-title":"FOSL1 transcriptionally dictates the Warburg effect and enhances chemoresistance in triple-negative breast cancer","volume":"23","author":"Zhao","year":"2025","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.bcp.2026.118260_b0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41419-023-05937-3","article-title":"Effects of altered glycolysis levels on CD8(+) T cell activation and function","volume":"14","author":"Cao","year":"2023","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bcp.2026.118260_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112186","article-title":"Accumulation of branched-chain amino acids reprograms glucose metabolism in CD8(+) T cells with enhanced effector function and anti-tumor response","volume":"42","author":"Yao","year":"2023","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.bcp.2026.118260_b0145","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1172\/JCI69589","article-title":"Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function","volume":"123","author":"Sukumar","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118260_b0150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.22203\/eCM.v048a05","article-title":"Peripheral blood cells enriched by adhesion to CYR61 are heterogenous myeloid modulators of tissue regeneration with early endothelial progenitor characteristics","volume":"48","author":"Herrmann","year":"2024","journal-title":"Eur. Cell. Mater."},{"key":"10.1016\/j.bcp.2026.118260_b0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.22203\/eCM.v047a08","article-title":"Extracellular matrix from hiPSC-mesenchymal progenitors modulates the three-lineage differentiation of human bone marrow stromal cells","volume":"47","author":"Hanetseder","year":"2024","journal-title":"Eur. Cell. Mater."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600599X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600599X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:27:34Z","timestamp":1791908854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522600599X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":31,"alternative-id":["S000629522600599X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118260","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EFO2 promotes triple-negative breast cancer progression and reduces CD8+ T cell-mediated killing by acetylating USF1 to enhance SLC2A1-mediated glycolysis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118260"}}